Silverarc Capital Management, LLC Amryt Pharma PLC Transaction History

Silverarc Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.68 - $7.58 $31,362 - $35,588	4,695 Added 2.49%	192,995 $1.41 Million
Q3 2022 Oct 28, 2022	BUY	$6.8 - $8.01 $81,538 - $96,047	11,991 Added 6.8%	188,300 $1.3 Million
Q2 2022 Jul 25, 2022	BUY	$6.85 - $8.87 $157,837 - $204,382	23,042 Added 15.03%	176,309 $1.23 Million
Q1 2022 May 13, 2022	SELL	$6.3 - $10.86 $1.24 Million - $2.14 Million	-196,946 Reduced 56.24%	153,267 $1.27 Million
Q4 2021 Feb 14, 2022	SELL	$9.44 - $12.24 $1.57 Million - $2.03 Million	-166,008 Reduced 32.16%	350,213 $3.78 Million
Q3 2021 Nov 15, 2021	BUY	$9.63 - $12.47 $574,756 - $744,259	59,684 Added 13.07%	516,221 $6.22 Million
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.29 $290,746 - $381,171	26,674 Added 6.21%	456,537 $5.54 Million
Q1 2021 May 18, 2021	BUY	$13.04 - $14.75 $356,083 - $402,778	27,307 Added 6.78%	429,863 $5.99 Million
Q4 2020 Feb 16, 2021	BUY	$12.22 - $14.16 $4.92 Million - $5.7 Million	402,556 New	402,556 $5.7 Million

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.